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  ♦ Background: Epithelial-to-mesenchymal transition (EMT) of 
human peritoneal mesothelial cells (HPMCs) contributes to fibrotic 
thickening of the peritoneum that develops in patients on perito-
neal dialysis (PD). The process is thought to be largely mediated 
by transforming growth factor-beta (TGF-β). As TGF-β has also 
been implicated in senescence of HPMCs, we have performed an 
exploratory study to examine if senescent HPMCs can undergo EMT. 
  ♦ Methods: Omentum-derived HPMCs were rendered senescent 
by repeated passages in culture. Features of EMT were assessed 
by immunostaining and quantitative polymerase chain reaction 
(qPCR) at various stages of the HPMC lifespan and after treatment 
with or without TGF-β. The motility of HPMCs was assessed in a 
scratch wound migration assay.
  ♦ Results: Replicative senescence of HPMCs was associated with 
a gradual increase in the constitutive expression of EMT markers, 
including increased production of extracellular matrix proteins. 
However, senescent HPMCs also retained epithelial cell features 
such as cytokeratin, calretinin, and E-cadherin and showed 
decreased, rather than increased, motility. In contrast, exposure 
to TGF-β resulted in an up-regulation of mesenchymal markers 
and down-regulation of epithelial markers. Such effects of TGF-β 
occurred both in young and senescent cells, although they were 
less pronounced in senescence. 
  ♦ Conclusions: Senescence of HPMCs is associated with spon-
taneous development of several EMT features. At the same time, 
senescent HPMCs preserve epithelial cell-like characteristics and 
are less prone to develop a full EMT phenotype in response to TGF-β. 
These observations may support the concept of cellular senescence 
being antagonistically pleiotropic with regard to EMT.
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A series of studies over the past 15 years has demonstrated that human peritoneal mesothelial cells (HPMCs) may 
undergo epithelial-to-mesenchymal transition (EMT) during 
peritoneal dialysis (PD) (reviewed in [1,2]). Although of mes-
enchymal origin, HPMCs normally display  a typical epithelial 
cell-like appearance. Over the course of EMT, however, they 
return to their mesenchymal phenotype and adopt a fibroblast-
like morphology, increase the production of extracellular 
matrix components, rearrange the cytoskeleton, and acquire 
the ability to migrate. The process of EMT is thought to be 
largely mediated by transforming growth factor-β (TGF-β) 
and controlled by transcription factors of the Snail, ZEB, and 
Twist families (3).
Transforming growth factor-β induces EMT in HPMCs (4) 
by engaging various mitogen-activated protein kinases 
(MAPKs) (5,6), as well as the nuclear transcription factor-κB 
(NF-κB) (7) and heat shock proteins (8). Adenovirus-mediated 
overexpression of TGF-β in the rat peritoneum leads to the 
up-regulation of genes involved in EMT and migration of 
mesothelial cells from the peritoneal surface monolayer into 
the sub-mesothelial stroma (9). 
The significance for PD of phenotypic conversion of HPMCs 
is that it is associated with an increase in the production of 
pro-fibrotic and pro-angiogenic mediators impinging on struc-
ture and function of the peritoneal membrane (1). However, 
the mechanism by which EMT is initiated during PD remains 
unclear. It has been demonstrated that PD fluids with high 
concentration of glucose degradation products can induce 
EMT both during short-term direct exposure in culture and, 
to a lesser extent, after chronic PD exposure in vivo (10,11). 
In addition to being a mediator of EMT, TGF-β is critically 
involved in cellular senescence, which emerged as an important 
process of tissue remodeling (see [12] for a recent review). In 
this respect, TGF-β has been shown to mediate such aspects 
of HPMC senescence as growth arrest, cell hypertrophy, and 
expression of senescence-associated β-galactosidase (SA-β-
Gal). Both HPMCs that senesce in vitro and HPMCs explanted 
from older donors secrete increased amounts of TGF-β, and 
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the magnitude of TGF-β release correlates inversely with the 
lifespan of HPMCs in culture (13). 
Given these roles of TGF-β, some kind of a relationship 
between cellular senescence and EMT is likely to exist. On the 
one hand, it is thought that by secreting increased amounts 
of bioactive molecules, senescent cells can promote EMT in 
neighboring cells (14). Indeed, it has been demonstrated that 
mesothelioma cells that entered senescence in response to 
chemotherapeutics became capable of inducing EMT in naïve 
non-senescent mesothelioma cells (15). On the other hand, 
the overexpression of EMT-controlling transcription factors 
inhibited growth suppressors and allowed the cells to bypass 
senescence (3,16). Conversely, inhibition of these factors 
resulted in cell cycle arrest, senescence (17), and insensitivity 
to TGF-β-driven EMT (18). 
While it appears that TGF-β may act as a driver of both EMT 
and cellular senescence in HPMCs, it is not clear what deter-
mines the choice of response to TGF-β. To shed some light on 
this relationship, we have carried out experiments to compare 
the ability of pre-senescent and senescent HPMCs to undergo 
TGF-β-induced EMT in culture.
METHODS
All chemicals, unless otherwise stated, were purchased from 
Sigma-Aldrich (St Louis, MO, USA). Tissue culture plastics were 
from Nunc (Roskilde, Denmark).
CELL CULTURE
Human peritoneal mesothelial cells were isolated by enzy-
matic digestion of the specimens of omentum removed from 
consenting patients undergoing elective abdominal surgery. 
The procedure was essentially as described elsewhere (19). 
Freshly isolated cells were identified as pure mesothelial by 
their typical cobblestone appearance at confluence and uni-
form positive staining for cytokeratin and calretinin, and nega-
tive staining for fibroblast-specific protein-1 (FSP-1) and von 
Willebrand factor. Immunostaining procedures were performed 
as previously described (20). Cells were maintained in the 
Earls’-buffered M199 medium supplemented with L-glutamine 
(2 mM), penicillin (100 U/mL), streptomycin (100 μg/mL), 
hydrocortisone (0.4 μg/mL), and 10% vol/vol fetal calf serum 
(Invitrogen, Karlsruhe, Germany).
INDUCTION OF CELL SENESCENCE
Replicative senescence of HPMCs was induced by serial pas-
sages, as earlier described in detail (21). Cells were considered 
senescent when they stopped increasing in number over 4 
weeks, showed distorted morphology, and stained positively 
for senescence-associated β-galactosidase (SA-β-Gal). 
Cytochemical assessment of SA-β-Gal was performed using 
the Senescence β-Galactosidase Staining Kit (Cell Signaling 
Technology, Beverly, MA, USA), according to the manufac-
turer’s instructions. Human peritoneal mesothelial cells reach 
senescence in vitro typically after 6 – 10 passages (21). Thus, 
in order to monitor changes that occur in HPMCs with time in 
culture, the cells were assessed at their first passage (young 
cells), third to fifth passage (middle-passage cells), and last 
passage (senescent cells). 
INDUCTION OF EMT
To induce EMT, HPMCs were incubated for 72 hours in nor-
mal culture medium supplemented with 1 ng/mL of human 
recombinant TGF-β1 (R&D Systems, Minneapolis, MN, USA). 
Such an exposure was previously shown to effectively induce 
EMT in HPMCs (4,22). 
SCRATCH WOUND HEALING ASSAY
The assessment of cell wound closure was performed as 
described in detail elsewhere (23,24). Briefly, HPMC monolay-
ers were scratch-wounded with a pipette tip, gently washed 
with medium to remove resulting debris and placed in an 
incubator coupled to an Axio Observer D1 inverted micro-
scope (Zeiss, Oberkochen, Germany). Cells were maintained 
in standard culture medium until wound closure. Cell images 
were acquired by time-lapse microscopy at 60-minute intervals 
and analyzed using the AxioVision Rel. 4.6.3 image analysis 
software (Zeiss). The rate of remesothelialization was calcu-
lated by measuring reduction in the denuded area over time.
IMMUNOSTAINING
Cells were grown on Lab-Tek Chamber Slides (Nunc) and fixed 
with 3.7% paraformaldehyde. Then, cells were permeabilized 
with 0.1% Triton X-100, blocked with 5% bovine serum albumin 
(BSA), and incubated with appropriate primary antibodies for 
1 hour at 37°C (Table 1). Antibodies were diluted in phosphate 
buffered saline (PBS) containing 0.1% BSA and 0.05% Tween 
20. The slides were then incubated with appropriate fluorescent 
Alexa dye-labeled secondary antibodies in PBS and counter-
stained with 4’,6-diamidino-2-phenylindole (DAPI) nuclear stain 
(all from Invitrogen/ThermoFisher Scientific, Waltham, MA, 
USA). Positively stained cells were counted by 2 independent 
observers in 5 randomly selected fields under a confocal micro-
scope (LSM710 Zeiss Confocal Microscope) at 400× magnifica-
tion, and expressed as a percentage of all DAPI-stained nuclei.
GENE EXPRESSION ANALYSIS
Expression of target genes was assessed with reverse tran-
scription and quantitative polymerase chain reaction (qPCR). 
Total RNA was extracted with RNA Bee (Tel-Test, Friendswood, TX, 
USA), purified with the RNeasy kit (Qiagen, Hamburg, Germany), 
quantified, and reverse-transcribed into complementary DNA 
(cDNA) using RNA PCR Core Kit (Applied Biosystems, Foster City, 
CA, USA). Quantitative PCR was carried out on a Light Cycler 2.0 
using a SYBR Green labeling kit (Roche, Mannheim, Germany) 
and specific primers for target genes (Table 2). The results were 
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calculated by the cycle threshold method and normalized for the 
endogenous reference (histone H3). 
STATISTICAL ANALYSIS
All experiments were performed in triplicate using cells 
from separate donors. Data are presented as mean ± standard 
error (SE).
RESULTS
As previously described (25), replicative senescence of 
HPMCs was accompanied by a gradual loss of their uniform 
cobblestone appearance. Instead, senescent cells became 
greatly enlarged, irregular and vacuolated, and stained exten-
sively for SA-β-Gal (Figure 1). Despite these profound changes 
in morphology, senescent cells still expressed epithelial and 
mesothelial cell markers—cytokeratin and calretinin (Figure 2). 
However, they also began to express increasingly mesenchymal 
markers—α-smooth muscle actin (α-SMA) and fibroblast-
specific protein (FSP)1. At the mRNA level, senescent HPMCs 
showed an increased expression of the transcription factor 
Snail, collagen 1, and fibronectin, and—interestingly—of 
E-cadherin (Figure 3A and B). The levels of TGF-β mRNA did 
not change considerably with senescence.
In order to assess whether senescence of HPMCs impacts 
their ability to undergo full EMT in response to TGF-β, the cells 
were treated with TGF-β at different stages of their lifespan in 
culture (Figures 2 and 3). Young HPMCs responded to TGF-β 
by developing typical features of EMT – inducing Snail, down-
regulating epithelial cell markers (cytokeratin, calretinin, 
E-cadherin), and up-regulating markers of myo-fibroblastic 
activity (FSP-1, α-SMA, collagen 1, fibronectin, TGF-β). A 
similar pattern of changes was also seen in middle-passage 
and senescent cells. However, there was a trend towards these 
effects of TGF-β becoming less pronounced, as expressed as 
a fold change in mRNA expression (Figure 3C). Notably, the 
induction of Snail and down-regulation of E-cadherin, cyto-
keratin, and calretinin was less evident in senescent cells. 
As EMT is a key step in mesothelial cell migration during 
wound healing, the rate of remesothelialization was assessed 
following scratch injury. These experiments demonstrated 
that the process of wound closure was delayed in cultures of 
senescent HPMCs (Figure 4). 
DISCUSSION
The main observation of the present study is that HPMCs 
undergoing replicative senescence in culture acquire some 
TABLE 1 
Antibodies Used Throughout the Study for Immunofluorescent Staining
Antibody Dilution Host Antibody type/clone
Catalog 
number Company
Anti-FSP-1 1:400 Rabbit Polyclonal A5114 Dako, Hamburg, Germany
Anti-cytokeratin 1:500 Mouse Monoclonal/pan antibody C5992 Sigma Aldrich, MO, USA
Anti-calretinin 1:200 Rabbit Monoclonal/EP1798 Ab92341 Abcam, Cambridge, UK
Anti-α-SMA 1:3000 Mouse Monoclonal/1A4 A5228 Sigma Aldrich, MO, USA 
Alexa Fluor 488 anti-mouse IgG 1:500 Donkey Polyclonal A21202 ThermoFisher Scientific, Waltham, MA, USA
Alexa Fluor 568 anti-rabbit IgG 1:500 Donkey Polyclonal A10042 ThermoFisher Scientific Waltham, MA, USA
TABLE 2 
Polymerase Chain Reaction Primer Pairs Used Throughout the Study
Gene Gen bank no. Forward primer Reverse primer Temp.
H3 M11353 5′-AAAGCCGCTCGCAAGAGTGCG-3′ 5′-ACTTGCCTCCTGCAAAGCAC-3′ 62°C
FN AB191261 5′-CCTGAAGCTGAAGAGACTTGC-3′ 5′-CGTTTCTCCGACCACATAGGA-3′ 66°C
COL-I NM_000088.3 5′-GCTATGATGAGAAATCAACCG-3′ 5′-GCTTCCCCATCATCTCCATTC-3′ 64°C
E-CADH NM_004360 5′-TGAACGTGACAGAGCCTCTG-3′ 5′-TGGGTGAATTCGGGCTTGTT-3′ 62°C
Snail1 NM_005985.3 5′-GCAAATACTGCAACAAGC-3′ 5′-GCACTGGTACTTCTTGACA-3′ 55°C
TGF-B1 NM_004048.2 5′-TGAACCGGCCTTTCCTGCTTCTCATG-3′ 5′-CGGAAGTCAATGTACAGCTGCCGC-3′ 60°C
Fig. 1. 
Young Senescent Middle-passage 
SA-β-Gal 
Figure 1 — Expression of senescence-associated β-galactosidase 
SA-β-Gal) by HPMCs. Cells at different stages of their lifespan in 
culture were analyzed by cytochemistry for SA-β-Gal (magnification 
40×, the scale bar corresponds to 100 μm). HPMC = human peritoneal 
mesothelial cell.
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phenotypic features consistent with EMT. In particular, they 
up-regulate Snail, a key transcriptional regulator of EMT. 
Moreover, they start expressing α-SMA, a marker of myofi-
broblasts, and FSP-1, a robust marker of fibroblasts and cells 
undergoing fibroblastic conversion (26). Accordingly, they 
also increase the expression of extracellular matrix proteins, 
collagen1, and fibronectin.
Intriguingly, however, having developed these EMT fea-
tures, senescent HPMCs did not entirely lose an epithelial cell 
structure and still expressed typical epithelial cell proteins 
such as cytokeratin, calretinin, and E-cadherin. Expression 
of the latter was even increased, which could be attributed to 
great enlargement of senescent cells (21). Nevertheless, the 
observation is surprising given that it was associated with 
increased expression of Snail, a transcriptional repressor of 
E-cadherin (27). It may suggest that senescent HPMCs did not 
undergo full EMT and displayed an intermediate phenotype with 
mesenchymal markers being already expressed and epithelial 
markers not yet down-regulated (28).
As TGF-β is thought to be necessary for both the early and 
late phases of EMT (29), we assessed the effect of TGF-β on 
EMT at various stages of senescence. It turned out that the 
expression of genes involved in EMT displayed a very similar 
pattern in young, middle-passaged, and senescent cells. 
However, the effects of TGF-β in senescent cells appeared to 
be not so prominent as in young cells. Notably, both young 
and senescent cells responded to TGF-β by down-regulating 
E-cadherin and cytokeratin, albeit the effect seen in senescent 
cells was less evident than in young cells. These data may sug-
gest that features of EMT present in senescent cells developed 
in a manner independent of TGF-β. Indeed, we did not observe 
an increase in TGF-β mRNA in senescent cells. Since earlier 
reports showed a significant increase in the release of active 
TGF-β by senescent HPMCs (13), our observations may point 
to a significant role of post-transcriptional mechanisms in 
increasing TGF-β release by senescent HPMCs. 
We have also detected that senescent HPMCs displayed 
decreased motility and migratory capacity, which led to delayed 
wound healing. In this respect, previous observations in ani-
mals have shown that the development of “incomplete” EMT 
with reduced mesothelial cell mobilization and a non-invasive 
phenotype may be mediated by platelet-derived growth factor 
B (30). More recently, it has been shown that EMT-activated 
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Figure 2 — Expression of epithelial and mesenchymal markers by HPMCs. Exemplary images of young, middle-passaged, and senescent cells 
immunostained for a panel of biomarkers expressed either constitutively (Control) or after stimulation with TGF-β1 (+TGF-β), as described in 
Methods. Cell nuclei were counterstained with DAPI (blue). Magnification 400×, scale bar = 25 μm. HPMC = human peritoneal mesothelial cell; 
TGF = transforming growth factor.
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biomarker-expressing cells with preserved contacts with neigh-
boring cells (31). 
Our data may thus suggest that cellular senescence hampers 
the development of a full EMT phenotype in HPMCs by retain-
ing their epithelial features. The fact that high expression 
of E-cadherin and cytokeratin occurred in the presence of 
increased Snail expression indicates that senescence repressed 
the Snail-mediated effects. Thus, given the proposed role of EMT 
in peritoneal fibrosis, HPMC senescence could act as an anti-
fibrotic mechanism. In this respect, it has been demonstrated 
that senescence of activated stellate cells can limit fibrosis of 
the liver (32). However, this concept may be at odds with the 
observation of increased expression of collagen and fibronectin 
by senescent HPMCs. These seemingly contradictory effects 
could be explained by antagonistic pleiotropy of senescent cells 
(33). On the one hand, by restraining EMT, cellular senescence 
of HPMCs can inhibit the development of peritoneal fibrosis. On 
the other hand, an increased production of extracellular matrix 
proteins may contribute to submesothelial fibrotic thickening. 
Another aspect of this apparent ambiguity could be an effect 
of TGF-β. By driving EMT, which is an essential part of wound 
healing, TGF-β promotes prompt wound closure. Indeed, it has 
been demonstrated that the treatment with TGF-β enhances 
cell motility and accelerates scratch wound healing in young 
mesothelial cells from rodents (34). However, by inducing cell 
senescence, TGF-β may indirectly delay tissue repair. Moreover, 
while small scratch wounds can close entirely by cell migration, 
the repopulation of larger injuries may require cell renewal. In 
this respect, mesothelial cell proliferation has been demon-
strated to be clearly and dose-dependently inhibited by TGF-β 
(35). In addition, TGF-β displays seemingly paradoxical effects 
on the inflammatory response. On the one hand, TGF-β controls 
the course of acute bacterial peritonitis in rats by dampening 
pro-inflammatory cytokine release from mesothelial cells (36). 
On the other hand, by inducing cellular senescence, TGF-β 
contributes to the development of the senescence-associated 
secretory phenotype that is characterized by a chronic increase 
in pro-inflammatory mediators release (37).
The existence of senescent HPMCs in vivo is difficult to docu-
ment. The presence of few SA-β-Gal-expressing mesothelial 
cells was detected in apparently normal human omentum 
(38). In the context of PD, it has been observed that some 
mesothelial cells shed from the peritoneal membrane into 
the dialysate may express senescent cell biomarkers SA-β-Gal 
and p16 (39). Mesothelial cells with senescence features have 
also been detected in peritoneal imprints taken from mice 
exposed to PD fluids and this effect has been attributed to 
osmotic agents in the dialysate (40). It has been hypothesized 
that dialysate glucose accelerates cell cycle progression and 
thus leads to earlier exhaustion of the growth capacity and/
or genotoxic stress that results in premature cell senescence 




Figure 3 — Expression of mRNAs for selected EMT markers in HPMCs undergoing senescence in the presence or absence of TGF-β. A) absolute 
expression levels as assessed by RT-qPCR; B) mRNAs expressed constitutively by HPMCs at different stages of senescence; the data are presented 
as a fold change from values seen in young cells; C) mRNAs expressed by HPMCs treated with TGF-β at different stages of senescence; the data 
are presented as a fold change from values recorded in the absence of TGF-β in young, middle-passaged, and senescent cells, respectively. All 
data were derived from 3 separate experiments with cells from different donors. EMT = epithelial-to-mesenchymal transition; HPMC = human 
peritoneal mesothelial cell; TGF = transforming growth factor; mRNA = messenger ribonucleic acid.
The single copy is for your personal, non-commercial use only. 
For permission to reprint multiple copies or to order presentation-ready 
 copies for distribution, contact Multimed Inc. at publishing_services@multi-med.com
40
KAWKA et al. JANUARY 2019 – VOL. 39, NO. 1 PDI
(41). Although the regeneration of mesothelial cells is likely 
to involve several mechanisms (see [42,43] for review), a 
decrease in the proliferative potential of progenitor/parent 
cells may hamper mesothelial cell recovery from PD fluid-
induced injuries and lead to depopulation of the mesothelial 
monolayer seen in peritoneal biopsies (44). 
CONCLUSIONS
It is not clear to what extent the process of replicative HPMC 
senescence in vitro reflects the biological status of HPMCs in 
vivo. It is believed that the potential of explanted cells to grow 
in culture depends on the proliferative history of cells, which 
is influenced both by the calendar age of the donor and by 
the previous environmental stresses. This complexity may be 
reflected by large heterogeneity in telomere length that can 
be seen in freshly isolated HPMCs (25). 
While the evidence of EMT was recorded in HPMCs isolated 
from the dialysis effluent (22), these cells were not analyzed 
for the senescence markers. Therefore, in future studies the 
simultaneous assessment of EMT and senescence in effluent-
derived HPMCs and in peritoneal biopsies may help to define 
exact molecular mechanisms linking these 2 processes. 
Interestingly, recent lineage tracing experiments in rodents 
demonstrated that EMT of mesothelial cells did not contribute 
significantly to the accumulation of myofibroblasts following 
peritoneal injury (45). In view of our findings it would be 
interesting to see if mesothelial cells expressed senescence 
markers under these conditions. 
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